Format

Send to

Choose Destination
Pediatr Dermatol. 2019 Jan;36(1):172-176. doi: 10.1111/pde.13707.

Use of dupilimab in pediatric atopic dermatitis: Access, dosing, and implications for managing severe atopic dermatitis.

Author information

1
Saint Louis University, Saint Louis, Missouri.
2
Cardinal Glennon Children's Hospital, Saint Louis, Missouri.
3
ApotheCom, Yardley, Pennsylvania.
4
Yale University School of Medicine, New Haven, Connecticut.
5
University of California, San Francisco School of Medicine, San Francisco, California.
6
Rady Children's Hospital, San Diego and University of California San Diego, School of Medicine, San Diego, California.
7
Dell Children's Medical Center of Central Texas and Dell Medical School, University of Texas at Austin, Austin, Texas.
8
Feinberg School of Medicine, Northwestern University and Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, Illinois.

KEYWORDS:

adverse effects; atopic dermatitis; biologic; dupilumab; pediatric drug use

PMID:
30675938
DOI:
10.1111/pde.13707

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center